IgG / soluble Ag / peptide Ag / Merck / HIV Ab / NCR / HIV Ag / Env Ag / BD Biosciences / Fauci A. S. / effector Ab / E. G. Rakasz S. P. / Immunologists Inc. / /
Country
Thailand / Jordan / United States / Australia / /
Currency
USD / / /
Event
FDA Phase / Product Issues / /
Facility
University of Melbourne / Alfred Hospital / †Melbourne Sexual Health Centre / §Burnet Institute / /
IndustryTerm
cleavage site / prevention of HIV / /
MedicalCondition
progressive HIV infection / HIV infection / Innate immune dysfunction / HIV / disease / rapidly expanding infection / viral infections / control HIV infection / cellular infection / AIDS / acute viremia / infection / asterixis / delayed disease / simian HIV infection / /
MedicalTreatment
antiretroviral therapy / vaccination / /
Organization
§Burnet Institute / Australian National Health and Medical Research Council / American Association of Immunologists / ‡Infectious Diseases Department / HIV-Specific Antibodies1 Amy W. Chung / * Erik Rollman / * Rob J. Center / Alfred Hospital / University of Melbourne / Melbourne / Department of Microbiology and Immunology / †Melbourne Sexual Health Centre / /
Person
Stephen J. Kent / Erik Rollman / M. Marthas / J. C. Becerra / K. S. Cole / Nat / G. Landucci / Amy W. Chung / C. E. Havenith / J. Kim / V / Ivan Stratov / K. Van Rompay / /
The Journal of Immunology Rapid Degranulation of NK Cells following Activation by HIV-Specific Antibodies1 Amy W. Chung,* Erik Rollman,* Rob J. Center,* Stephen J. Kent,2*†‡ and Ivan Stratov*†‡§ Ab-dependent ce